These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36581261)

  • 1. Orthogonal and complementary measurements of properties of drug products containing nanomaterials.
    Simon CG; Borgos SE; Calzolai L; Nelson BC; Parot J; Petersen EJ; Roesslein M; Xu X; Caputo F
    J Control Release; 2023 Feb; 354():120-127. PubMed ID: 36581261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity.
    Caputo F; Clogston J; Calzolai L; Rösslein M; Prina-Mello A
    J Control Release; 2019 Apr; 299():31-43. PubMed ID: 30797868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
    Zolnik BS; Sadrieh N
    Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring particle concentration of multimodal synthetic reference materials and extracellular vesicles with orthogonal techniques: Who is up to the challenge?
    Vogel R; Savage J; Muzard J; Camera GD; Vella G; Law A; Marchioni M; Mehn D; Geiss O; Peacock B; Aubert D; Calzolai L; Caputo F; Prina-Mello A
    J Extracell Vesicles; 2021 Jan; 10(3):e12052. PubMed ID: 33473263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Summary report of PQRI Workshop on Nanomaterial in Drug Products: current experience and management of potential risks.
    Bartlett JA; Brewster M; Brown P; Cabral-Lilly D; Cruz CN; David R; Eickhoff WM; Haubenreisser S; Jacobs A; Malinoski F; Morefield E; Nalubola R; Prud'homme RK; Sadrieh N; Sayes CM; Shahbazian H; Subbarao N; Tamarkin L; Tyner K; Uppoor R; Whittaker-Caulk M; Zamboni W
    AAPS J; 2015 Jan; 17(1):44-64. PubMed ID: 25421459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques.
    Markova N; Cairns S; Jankevics-Jones H; Kaszuba M; Caputo F; Parot J
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
    Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
    Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials".
    de Vlieger JSB; Crommelin DJA; Tyner K; Drummond DC; Jiang W; McNeil SE; Neervannan S; Crist RM; Shah VP
    AAPS J; 2019 Apr; 21(4):56. PubMed ID: 30997588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The carcinogenic potential of nanomaterials, their release from products and options for regulating them.
    Becker H; Herzberg F; Schulte A; Kolossa-Gehring M
    Int J Hyg Environ Health; 2011 Jun; 214(3):231-8. PubMed ID: 21168363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.
    Caputo F; Arnould A; Bacia M; Ling WL; Rustique E; Texier I; Mello AP; Couffin AC
    Mol Pharm; 2019 Feb; 16(2):756-767. PubMed ID: 30604620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional DNA-containing nanomaterials: cellular applications in biosensing, imaging, and targeted therapy.
    Liang H; Zhang XB; Lv Y; Gong L; Wang R; Zhu X; Yang R; Tan W
    Acc Chem Res; 2014 Jun; 47(6):1891-901. PubMed ID: 24780000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H; Ogawa K; Kato N; Kawakami S
    Drug Metab Pharmacokinet; 2022 Jun; 44():100450. PubMed ID: 35381574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [International trend of guidance for nanomaterial risk assessment].
    Hirose A
    Yakugaku Zasshi; 2013; 133(2):175-80. PubMed ID: 23370509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accurate quantification of TiO
    Velimirovic M; Wagner S; Monikh FA; Uusimäki T; Kaegi R; Hofmann T; Kammer FV
    Talanta; 2020 Aug; 215():120921. PubMed ID: 32312463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells.
    Roesch A; Zölls S; Stadler D; Helbig C; Wuchner K; Kersten G; Hawe A; Jiskoot W; Menzen T
    J Pharm Sci; 2022 Apr; 111(4):933-950. PubMed ID: 34919969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.